
    
      Primary endpoint: Overall survival (OS), Secondary endpoints: Progression-free survival
      (PFS), Time to treatment failure (TTF), Overall response rate (ORR),Disease Control Rate
      (DCR), Relative dose intensity, Safety, and Correlation between UGT1A1 genotype and Safety.
    
  